CT-045主要结果:Lisocabtagene Maraleucel (Liso-Cel)在社区作为复发或难治性(R/R)大b细胞淋巴瘤(LBCL)患者门诊或住院治疗的II期研究

{"title":"CT-045主要结果:Lisocabtagene Maraleucel (Liso-Cel)在社区作为复发或难治性(R/R)大b细胞淋巴瘤(LBCL)患者门诊或住院治疗的II期研究","authors":"Y. Linhares, C. Freytes, M. Cherry, C. Bachier, Michael Maris, D. Hoda, J. Varela, Courtney Bellomo, Scott Cross, J. Essell, S. Fanning, H. Terebelo, H. Yimer, Jay Courtright, J. Sharman, A. Kostić, M. Vedal, K. Ogasawara, A. Avilion, R. Espinola, Brenda Yuan, B. Mattar","doi":"10.1016/s2152-2650(23)01482-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)\",\"authors\":\"Y. Linhares, C. Freytes, M. Cherry, C. Bachier, Michael Maris, D. Hoda, J. Varela, Courtney Bellomo, Scott Cross, J. Essell, S. Fanning, H. Terebelo, H. Yimer, Jay Courtright, J. Sharman, A. Kostić, M. Vedal, K. Ogasawara, A. Avilion, R. Espinola, Brenda Yuan, B. Mattar\",\"doi\":\"10.1016/s2152-2650(23)01482-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"47 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)01482-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)01482-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}